U.S. markets open in 6 hours 37 minutes

Arcus Biosciences, Inc. (RCUS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
20.33+0.83 (+4.26%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/16/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
1.32B1.14B638.12M463.18M417.23M
Enterprise Value 3
855.77M981.31M449.85M272.19M192.83M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
61.2172.6040.5564.3342.15
Price/Book (mrq)
3.0710.373.902.622.12
Enterprise Value/Revenue 3
57.05560.75257.0627.92110.19
Enterprise Value/EBITDA 6
-7.70-22.01-16.32-16.33-8.62

Trading Information

Stock Price History

Beta (5Y Monthly) 1.31
52-Week Change 3150.37%
S&P500 52-Week Change 314.26%
52 Week High 337.41
52 Week Low 37.19
50-Day Moving Average 319.73
200-Day Moving Average 324.25

Share Statistics

Avg Vol (3 month) 3506.63k
Avg Vol (10 day) 3483.3k
Shares Outstanding 564.91M
Float 44.39M
% Held by Insiders 128.97%
% Held by Institutions 153.08%
Shares Short (Sep 29, 2020) 46.47M
Short Ratio (Sep 29, 2020) 411.31
Short % of Float (Sep 29, 2020) 412.56%
Short % of Shares Outstanding (Sep 29, 2020) 49.97%
Shares Short (prior month Aug 30, 2020) 45.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-763.68%

Management Effectiveness

Return on Assets (ttm)-19.88%
Return on Equity (ttm)-35.75%

Income Statement

Revenue (ttm)15M
Revenue Per Share (ttm)0.33
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)-63.48M
EBITDA -111.18M
Net Income Avi to Common (ttm)-111.78M
Diluted EPS (ttm)-2.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)462.47M
Total Cash Per Share (mrq)7.12
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.78
Book Value Per Share (mrq)7.27

Cash Flow Statement

Operating Cash Flow (ttm)-92.08M
Levered Free Cash Flow (ttm)-48.6M